-
Most Americans believe that screening tests for cancer save lives and that it is irresponsible not to undergo recommended periodic screening. The presence of a large market for cancer screening may make Americans vulnerable to unproven and unnecessary testing.
-
Beksinska and colleagues from South Africa measured FSH levels in long-term older users of depot-medroxyprogesterone acetate (117 women) and norethindrone enanthate (60 women), long-acting progestin-only methods of contraception.
-
-
Oral rofecoxib (Vioxx) may have a role in controlling postoperative pain patients undergoing knee surgery.
-
-
The management of advanced, hormone-resistant prostate cancer remains challenging.
-
Controversy exists regarding the best approach to early epidermoid cancers of the lip. Various approaches have been advocated, including surgery with or without postoperative radiotherapy, and low- dose rate (LDR) brachytherapy.
-
The arimidex, tamoxifen alone or in combination (ATAC) trial is a large-scale, international, industry-sponsored interventional, randomized study involving almost 10,000 early-stage postmenopausal breast cancer patients who were randomized to receive either anastrozole alone or in combination with tamoxifen, or tamoxifen alone.
-
-
A substantial difference in clinical quality was found between the winners of the Health Grades Inc./J.D. Power & Associates Distinguished Hospital Award for Clinical Excellence winners and all other hospitals, Health Grades Inc. reports.
